1. Annual Report 2025
  2. Research
  3. GAVINA

GAVINA

Group for the Evaluation of Interventions in Primary Care

The GAVINA research group carries out scientifically rigorous studies to evaluate health interventions and their implementation in the clinical practice of Primary Care, which provide evidence for decision-making in care and help to improve the development of the daily work of health professionals.

The group is multidisciplinary and is organized into 11 doctoral researchers.

Group projects

  • Nuevo abordaje de la violencia machista en atención primaria basado en un algoritmo de inteligencia artificial y formación al profesional, con un proceso participativo: Proyecto Vioketa. (PI24/01132). Instituto de Salud Carlos III. 2025-2027. IP: Carina Aguilar Martín.

  • Nou abordatge de la violència masclista en Atenció Primària basat en un algorisme d'intel·ligència artificial i formació al professional: Projecte Violeta. ICS - Institut Català de la Salut. 2025-2028. IP: Enric Bachrani Reverté.

  • Herramienta avanzada de soporte a la fibrilación auricular para prevenir el Ictus "FIBRILEX". (DTS25/00007). ICS - Institut Català de la Salut; Instituto de Salud Carlos III. 2025-2028. IP: Maria Rosa Dalmau Llorca.

  • Efectividad de una herramienta informática para adecuar en tratamiento anticoagulante en fibrilación auricular no valvular (Fantas-Tic). (PI21/01435). Instituto de Salud Carlos III. 2021-2025. IP: Maria Rosa Dalmau Llorca.

  • Cost efectivitat i implementació d'una eina basada en el temps en rang terapèutic per a millorar la presa de decisions mèdiques en Fibril·lació Auricular No Valvular (Cds-Nvaf) a l'Atenció Primària de Catalunya. (SLT/21/000010). 2022-2025. IP: Maria Rosa Dalmau Llorca.

  • Asociación entre el tratamiento Asociación entre el tratamiento antiagregante o anticoagulante y la incidencia de ictus isquémicos en pacientes con fibrilación auricular en Cataluña. 2024-2027. IP: Maria Rosa Dalmau Llorca.

  • Adherència a tractaments en malalties cròniques: anàlisi a l'atenció primària (Adhecap: Adherència Crònica Atenció Primària). ICS - Institut Català de la Salut. 2025-2028. IP: Zojaina Hernández Rojas.

  • Xarelto Paediatric Vte Pass Drug Utilization Study: An observational, longitudinal, multi-source drug utilization safety study to evaluate the drug use patterns and safety of rivaroxaban oral suspension in children under two years with venous thromboembolism (XAPAEDUS). Bayer AG. 2024-2029. IP: Maria Rosa Dalmau Llorca.

  • Avaluacions econòmiques a l'atenció primària. (INTENS-23/8). ICS - Institut Català de la Salut. 2024-2026. IP: Zojaina Hernández Rojas.

  • Avaluació i innovació en intervencions sanitàries per millorar la presa de decisions i els resultats de salut. (SLT042/25/000003). Generalitat Catalunya. 2025-2029. IP: Maria Rosa Dalmau Llorca.

Group publications

  • Paniagua Asensio ML, Rubio Rico L, Fernández Sáez J, Marsá Fadurdo C, Dominguez Paniagua A, Roca Biosca A. The effect of nursing training on dependence-related skin lesions: a quasi-experimental study. J. Wound Care. 2025;34(9):754-762. PMID:40906622.

  • Naharro E, Blandón J, Sillero AS, Sáez JF. The Economic and Occupational Impact of Mental Health-Related Temporary Work Disabilities in Spanish Workers During and After the COVID-19 Pandemic: A Longitudinal Study. Healthcare. 2025;13(6): PMID:40150468.

  • López Contreras N, López Jiménez T, Medina Perucha L, León Gómez BB, Gonçalves AQ, Horna Campos OJ et al. Syndemic, mental health and living with dependent persons in Latin America and Spain: a study with a gender perspective. Arch. PUblic Health. 2025;83(1):24-24. PMID:39863880.

  • Zaldua YC, Martin SM, Bret JS, Perez EH, Redon EC, Noguerola SR. Simulated Clinical Stations in Quality and Patient Safety in a Primary Care Setting. Healthcare. 2025;13(13): PMID:40648526.

  • Gutiérrez Naharro EM, Sillero A, Ponce Blandón JA, Fernández Sáez J. Sex Differences in Mental Health-Related Work Incapacity Across Occupational Sectors During the COVID-19 Lockdown in Spain. Healthcare. 2025;13(10): PMID:40427973.

  • Perramon Malavez A, Buonsenso D, Morello R, Coma E, Foster S, Leonard P et al. Real-world impact of nirsevimab immunisation against respiratory disease on emergency department attendances and admissions among infants: a multinational retrospective analysis. Lancet Reg. Health-Eur. 2025;55101334-101334. PMID:40950943.

  • Haro Montoya M, Caballol Angelats R, Fernández Sáez J, Montelongo Sol M, Conangla Ferrin L, Cendrós Cámara V et al. Prognostic Utility of HEFESTOS Score and Complementary Lung Ultrasound for Heart Failure Decompensation in Primary Care Outpatients: A Prospective Cohort Study. J. Cardiovasc. Dev. Dis. 2025;12(9): PMID:41002626.

  • Hernández Rojas Z, Dalmau Llorca MR, Aguilar Martín C, Castro Blanco E, García Goñi M, Alegret JM. Population-based analysis of the cost of direct oral anticoagulants versus vitamin K antagonists in nonvalvular atrial fibrillation. Rev. Esp. Cardiol. 2025;78(7):652-655. PMID:40097002.

  • Arévalo Chico H, Sellés Pérez S, Fernández Sáez J, Cejuela R. Physiologic Performance, Training, and Its Evolution in International- Versus National-Level Triathletes of Both Sexes: What Differences Are There?. J. Strength Cond. Res. 2025;39(7):770-779. PMID:40267406.

  • Gutiérrez Naharro EM, Fernández Sáez J, Sillero A, Tolo Espinet P, Ponce Blandón JA. Mental Health-Related Work Disabilities During the COVID-19 Lockdown in Spain: A Retrospective Analysis. Healthcare. 2025;13(3): PMID:39942425.

  • Bodoque Cubas J, Fernández Sáez J, Martínez Hervás S, Pérez Lacasta MJ, Carles Lavila M, Pallarés Gasulla RM et al. Integrating Artificial Intelligence in Thyroid Nodule Management: Clinical Outcomes and Cost-effectiveness Analysis. J. Clin. Endocrinol. Metab. 2025;111(2):405-417. PMID:40650885.

  • Reverté Villarroya S, Gil Mateu E, Fernández Sáez J, Martorell Poveda MA, Raventós Torner R, Barceló Prats J. Influence of a b-learning model to improve perceived stressors in final-year nursing students during clinical placements: a quasi-experimental study. BMC Nurs. 2025;25(1):34-34. PMID:41366389.

  • Coma E, Martinez Marcos M, Hermosilla E, Mendioroz J, Reñe A, Fina F et al. Impact of nirsevimab immunoprophylaxis on respiratory syncytial virus-related outcomes inhospital and primary care after two consecutive seasons: a population-based retrospective cohort study in infants in their second year of life in Catalonia, Spain. Eur. J. Pediatr. 2025;184(10):616-616. PMID:40946115.

  • Pla Canalda E, Jimenez Herrera M, Fernández Sáez J, Concha Martinez P, Martinez Segura E. Impact of Educational Intervention on Noninvasive Ventilation (NIV) in Nurses and Students. Clin. Teach. 2025;22(5): PMID:40814240.

  • Torrubia Pérez E, Martorell Poveda MA, Fernández Sáez J, Barberà MM, Reverté Villarroya S. Gender Differential Morbidity in Quality of Life and Coping Among People Diagnosed with Depression and Anxiety Disorders. Healthcare. 2025;13(7): PMID:40218003.

  • Esteban Fabró R, Coma E, Marin Gomez FX, Hermosilla E, Mendez Boo L, Guiriguet C et al. Financial incentives and information provision for post-pandemic primary care quality recovery: a longitudinal study in Catalonia. Br. J. Gen. Pract. 2026; PMID:41344817.

  • González Sánchez A, Andrés C, Prats Méndez I, Piñana M, Coma E, Bernet A et al. Evolutionary dynamics of HRSV following the implementation of nirsevimab immunoprophylaxis in Catalonia (2023-2024). J. Infect. 2025;91(3):106567-106567. PMID:40769426.

  • Guiriguet C, Bustos M, Cantenys R, Hermosilla E, Camús J, Medina M et al. Enhancing the follow-up for patients with type 2 diabetes mellitus using a proactive scheduling computer tool: A paired cohort study in primary care. Prim. Care Diabetes. 2025;19(3):334-340. PMID:40157873.

  • Perramon Malavez A, Hermosilla E, Coma E, Fina F, Reñé A, Martínez Marcos M et al. Effectiveness of Nirsevimab Immunoprophylaxis Against Respiratory Syncytial Virus-related Outcomes in Hospital Care Settings: A Seasonal Cohort Study of Infants in Catalonia (Spain). Pediatr. Infect. Dis. J. 2025;44(5):394-398. PMID:39823640.

  • Coma E, Martinez Marcos M, Hermosilla E, Mendioroz J, Rene A, Avilés FF et al. Effectiveness of nirsevimab against RSV-related outcomes: findings of the 2024-2025 campaign in Catalonia align with previous analysis. Arch. Dis. Child. 2025;110(12):1024-1025. PMID:40499942.

  • Dalmau Llorca MR, Hernández Rojas Z, Castro Blanco E, Carrasco Querol N, Gonçalves AQ, Espuny Cid A et al. Clinical Outcome and Costs Based on the Degree of Vitamin K Antagonist Control for Non-Valvular Atrial Fibrillation. J. Clin. Med. 2025;14(3): PMID:39941667.

  • Cruz A, Gonçalves AQ, Vázquez Villegas J, Vallejo Godoy S, Álvarez Ossorio R, Requena P et al. Adapting the implementation of clinical practice guidelines for the screening of infectious diseases and female genital mutilation/cutting in migrants in Spain. Int. J. Infect. Dis. 2026;163108259-108259. PMID:41325924.

Proceeding Papers

  • Cruz A, Gonçalves AQ, Vázquez Villegas J, Cuxart Graell A, Vallejo Godoy S, Alvarez Ossorio R et al. Individualized screening of infectious diseases and female genital mutilation in the migrant population: Adapting clinical practice guidelines to the primary care context. Eur. J. Public Health. 2025;35

Theses

  • Castro E. Modelo matemático para predecir la epidemia de gripe. Universidad Rovira i Virgili. 2025.

Anar a l'inici